Investments in Cancer Control Research

For 25 years, researchers funded by DCCPS have been advancing the science to improve public health. Major programmatic areas of research include epidemiology and genomics, behavioral health, health care delivery, surveillance, and cancer survivorship.

In fiscal year (FY) 2022, DCCPS funded 854 grants valued at more than $558 million, supporting work in the US and internationally aimed to reduce risk, incidence, and deaths from cancer, and to enhance the quality of life for cancer survivors. In addition, the division funded $99 million in contracts, which include the Surveillance, Epidemiology, and End Results (SEER) Program. While the majority of DCCPS funding is for investigator-initiated research project grants, the division also uses other strategies to support and stimulate research, such as multi-component specialized research centers, cancer epidemiology cohorts, and supplements to NCI-Designated Cancer Center support grants.

Learn more about the DCCPS grant portfolio and funding trends at maps.cancer.gov/overview/.